World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Technical Report Series 894. World Health Organization; 2000. p. 1–253.

Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, et al. Perzentile für den body-mass-index für das kindes- und jugendalter unter heranziehung verschiedener deutscher stichproben. Monatsschrift Kinderheilkunde. 2001;149:807–18.

Article  Google Scholar 

Kromeyer-Hauschild K, Moss A, Wabitsch M. Referenzwerte für den Body-Mass-Index für Kinder, Jugendliche und Erwachsene in Deutschland: Anpassung der AGA-BMI-Referenz im Altersbereich von 15 bis 18 Jahren. Adipositas. 2015;9:123–7.

Google Scholar 

Nowell H Phelps, Rosie K Singleton, Bin Zhou, Rachel A Heap, Anu Mishra, James E Bennett, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403:1027–50.

Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Curr Obes Rep. 2015;4:363–70.

Article  PubMed  Google Scholar 

Thaker VV. Genetic and epigenetic causes of obesity. Adolesc Med State Art Rev. 2017;28:379–405.

PubMed  PubMed Central  Google Scholar 

Hinney A, Körner A, Fischer-Posovszky P. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits. Nat Rev Endocrinol. 2022;18:623–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bouchard C. Genetics of obesity: what we have learned over decades of research. Obesity. 2021;29:802–20.

Article  PubMed  Google Scholar 

Albert J Stunkard, Terryl T Foch, Zdenek Hrubec. A twin study of human obesity. JAMA. 1986; 256:51–4.

Thomsen SF, Ulrik CS, Kyvik KO, Sørensen TIA, Posthuma D, Skadhauge LR, et al. Association between obesity and asthma in a twin cohort. Allergy. 2007;62:1199–204.

Article  CAS  PubMed  Google Scholar 

Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120–33.

Article  CAS  PubMed  Google Scholar 

Khera AV, Chaffin M, Wade KH, Zahid S, Brancale J, Xia R, et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell. 2019;177:587–596.e9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleyn P, Ichetovkin I, Moeller I. eP125: variants in obesity-related genes in a population with early-onset obesity. Genet Med. 2022;24:S78.

Article  Google Scholar 

Kleinendorst L, Massink MPG, Cooiman MI, Savas M, van der Baan-Slootweg OH, Roelants RJ, et al. Genetic obesity: next-generation sequencing results of 1230 patients with obesity. J Med Genet. 2018;55:578–86.

Article  CAS  PubMed  Google Scholar 

Kleinendorst L, Abawi O, van der Voorn B, Jongejan MHTM, Brandsma AE, Visser JA, et al. Identifying underlying medical causes of pediatric obesity: results of a systematic diagnostic approach in a pediatric obesity center. PLoS ONE. 2020;15:e0232990.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferraz Barbosa B, Aquino de Moraes FC, Bordignon Barbosa C, Palavicini Santos PTK, Pereira da Silva I, Araujo Alves da Silva B, et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, for obese patients: a systematic review and meta-analysis. J Pers Med. 2023;13:1460.

Article  PubMed  PubMed Central  Google Scholar 

Faccioli N, Poitou C, Clément K, Dubern B. Current treatments for patients with genetic obesity. J Clin Res Pediatr Endocrinol. 2023;15:108–19.

Article  PubMed  PubMed Central  Google Scholar 

AbouHashem N, Zaied RE, Al-Shafai K, Nofal M, Syed N, Al-Shafai M. The spectrum of genetic variants associated with the development of monogenic obesity in Qatar. Obes Facts. 2022;15:357–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts KJ, Ariza AJ, Selvaraj K, Quadri M, Mangarelli C, Neault S, et al. Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program. Int J Obes. 2022;46:1493–501.

Article  CAS  Google Scholar 

Tamaroff J, Williamson D, Slaughter JC, Xu M, Srivastava G, Shoemaker AH. Prevalence of genetic causes of obesity in clinical practice. Obes Sci Pract. 2023;9:508–15.

Article  PubMed  PubMed Central  Google Scholar 

Hendricks AE, Bochukova EG, Marenne G, Keogh JM, Atanassova N, Bounds R, et al. Rare variant analysis of human and rodent obesity genes in individuals with severe childhood obesity. Sci Rep. 2017;7:4394.

Article  PubMed  PubMed Central  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

Article  PubMed  PubMed Central  Google Scholar 

Ellard S, Baple EL, Berry I, Forrester N, Turnbull C, Owens M, et al. ACGS best practice guidelines for variant classification. ACGS. 2019;2019:1–32.

Google Scholar 

Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA. Online Mendelian Inheritance in Man (OMIM). Hum Mutat. 2000;15:57–61.

Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews® [Internet]: Seattle (WA): University of Washington, Seattle; 1993–2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1116/.

Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019;51:1560–65.

Genomics England PanelApp: Severe early-onset obesity, version 4.10; 1 July, 2024. Available from: https://panelapp.genomicsengland.co.uk.

Duis J, Butler MG. Syndromic and nonsyndromic obesity: underlying genetic causes in humans. Adv Biol. 2022;6:e2101154.

Article  Google Scholar 

Voigtmann F, Wolf P, Landgraf K, Stein R, Kratzsch J, Schmitz S, et al. Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity. Metabolism. 2021;116:154438.

Article  CAS  PubMed  Google Scholar 

Schienkiewitz A, Kuhnert R, Blume M, Mensink GBM. Overweight and obesity among adults in Germany—results from GEDA 2019/2020-EHIS. J Health Monit. 2022;7:21–8.

PubMed  PubMed Central  Google Scholar 

Dingemans, Jansen AJM, van Reeuwijk S, Leeuw J, de N, Pfundt R, et al. Prevalence of comorbidities in individuals with neurodevelopmental disorders from the aggregated phenomics data of 51,227 pediatric individuals. Nat Med. 2024;30:1994–2003.

Article  CAS  PubMed  Google Scholar 

Vinkšel M, Writzl K, Maver A, Peterlin B. Improving diagnostics of rare genetic diseases with NGS approaches. J Community Genet. 2021;12:247–56.

Article  PubMed  PubMed Central  Google Scholar 

Thompson MD. Innovations in phenotyping and diagnostics create opportunities for improved treatment and genetic counseling for rare diseases. Genes. 2024;15:715.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chami N, Preuss M, Walker RW, Moscati A, Loos RJF. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population. PLoS Med. 2020;17:e1003196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S, et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med. 2010;12:641–7.

Article  PubMed  Google Scholar 

Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, et al. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet. 2012;49:660–8.

Article  CAS  PubMed  Google Scholar 

Vos N, Kleinendorst L, van der Laan L, van Uhm J, Jansen PR, van Eeghen AM, et al. Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options. Eur J Hum Genet. 2024;32:1387–1401.

Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Investig. 2007;117:397–406.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Webster E, Cho MT, Alexander N, Desai S, Naidu S, Bekheirnia MR, et al. De novo PHIP-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features. Cold Spring Harb Mol Case Stud. 2016;2:a001172.

Article  PubMed